Home › Chronic Kidney Disease › New Jersey › Brick
Chronic Kidney Disease clinical trials in Brick, NJ
3 studies for Chronic Kidney Disease are looking for participants at sites in and around Brick (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Eatontown · 17 mi away
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
- Hackensack Meridian Health, Neptune City · 11 mi away
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RecruitingPhase 3
- Research Site, Eatontown · 17 mi away
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY16 studies
- Philadelphia, PA15 studies
- Boston, MA15 studies
- Houston, TX14 studies
- Dallas, TX14 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA9 studies
- Kansas City, MO8 studies
- San Antonio, TX8 studies
- Durham, NC8 studies
- Los Angeles, CA7 studies
Other studies in Brick
- Acute Myeloid Leukemia7 studies
- Breast Cancer6 studies
- Nausea and Vomiting4 studies
- Non-Small Cell Lung Cancer4 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Cancer (all types)3 studies
- Obesity3 studies
- Heart Failure3 studies
- Colon Cancer3 studies
- Melanoma3 studies
- Myeloproliferative Neoplasms3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.